Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MLAB 
Mesa Laboratories Inc (MLAB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: MLAB (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $88.5
1 Year Target Price $88.5
| 2 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -51.1% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 339.22M USD | Price to earnings Ratio - | 1Y Target Price 88.5 |
Price to earnings Ratio - | 1Y Target Price 88.5 | ||
Volume (30-day avg) 4 | Beta 0.82 | 52 Weeks Range 55.32 - 154.33 | Updated Date 09/15/2025 |
52 Weeks Range 55.32 - 154.33 | Updated Date 09/15/2025 | ||
Dividends yield (FY) 1.01% | Basic EPS (TTM) -0.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.26% | Operating Margin (TTM) 5.15% |
Management Effectiveness
Return on Assets (TTM) 2.04% | Return on Equity (TTM) -0.38% |
Valuation
Trailing PE - | Forward PE 35.21 | Enterprise Value 515533653 | Price to Sales(TTM) 1.4 |
Enterprise Value 515533653 | Price to Sales(TTM) 1.4 | ||
Enterprise Value to Revenue 2.13 | Enterprise Value to EBITDA 11.38 | Shares Outstanding 5501450 | Shares Floating 5335750 |
Shares Outstanding 5501450 | Shares Floating 5335750 | ||
Percent Insiders 5.29 | Percent Institutions 96.22 |
Upturn AI SWOT
Mesa Laboratories Inc
Company Overview
History and Background
Mesa Laboratories, Inc. was founded in 1982. Initially focused on providing process validation and monitoring equipment, it has grown through acquisitions and organic growth to offer a broader range of products and services in the healthcare, industrial, and pharmaceutical sectors.
Core Business Areas
- Sterilization and Disinfection Control: Mesa provides biological indicators and process challenge devices used to monitor sterilization and disinfection processes, ensuring medical device and pharmaceutical product safety.
- Continuous Monitoring: Offers systems for continuous environmental monitoring, primarily for pharmaceutical and biotechnology companies, including temperature, humidity, and differential pressure monitoring.
- Instruments: Designs and manufactures precision measurement instruments for a range of applications, including calibration, validation, and testing of critical parameters.
Leadership and Structure
The leadership team consists of the CEO, CFO, and various VPs overseeing different business segments. The organizational structure is departmentalized and hierarchical, focused on specialized expertise and innovation.
Top Products and Market Share
Key Offerings
- Biological Indicators: Mesa is a leading provider of biological indicators (BIs) used to validate sterilization processes. They hold a significant market share in this niche market, competing with companies like STERIS and 3M. Revenue derived is confidential. Used in Sterilizers, Autoclaves and Medical Equipments.
- Data Loggers: Mesa offers data loggers for temperature and humidity monitoring, particularly in the pharmaceutical industry. Competitors include Vaisala and Dickson. Market share data is fragmented and confidential. Used to monitor temperature and humidity and pressure.
Market Dynamics
Industry Overview
The market for sterilization and disinfection control, environmental monitoring, and precision instruments is driven by increasing regulatory requirements, growing awareness of infection control, and the expansion of the pharmaceutical and biotechnology industries.
Positioning
Mesa Laboratories is positioned as a specialized provider of high-quality, regulatory-compliant solutions. Its competitive advantage lies in its deep expertise, strong brand reputation, and focus on niche applications.
Total Addressable Market (TAM)
The TAM for Mesa's combined markets is estimated to be several billion USD annually. Mesa is positioned to address segments within that total market by focusing on specialized and high-growth areas.
Upturn SWOT Analysis
Strengths
- Strong Brand Reputation
- Deep Expertise in Niche Markets
- High-Quality Products
- Regulatory Compliance Focus
- Recurring Revenue Streams
Weaknesses
- Limited Scale Compared to Larger Competitors
- Dependence on Specific Industries
- Potential for Product Liability Claims
- Higher Valuation than some competitors
- Limited Product Diversification
Opportunities
- Expanding into New Geographies
- Developing Innovative Products
- Acquiring Complementary Businesses
- Capitalizing on Increased Regulatory Scrutiny
- Growing Demand for Environmental Monitoring Solutions
Threats
- Increased Competition
- Changes in Regulatory Requirements
- Economic Downturn
- Technological Obsolescence
- Supply Chain Disruptions
Competitors and Market Share
Key Competitors
- STERIS (STE)
- 3M (MMM)
- Vaisala (VAI.HE)
Competitive Landscape
Mesa faces competition from larger, more diversified companies, but it maintains a competitive edge through its specialized expertise and focus on niche markets.
Major Acquisitions
Gyros Protein Technologies
- Year: 2022
- Acquisition Price (USD millions): 247.5
- Strategic Rationale: Expanded Mesa's analytical instrument offerings and strengthened its position in biopharmaceutical development.
Growth Trajectory and Initiatives
Historical Growth: Mesa has achieved growth through acquisitions and organic expansion.
Future Projections: Future growth projections depend on market conditions and strategic execution.
Recent Initiatives: Recent initiatives focus on product development and market expansion.
Summary
Mesa Laboratories is a specialized player in sterilization and disinfection control, offering niche products within the healthcare and pharmaceutical sectors. The company benefits from strong brand reputation and regulatory tailwinds. However, its limited scale and higher valuation compared to competitors may present challenges. Growth depends on product development, strategic acquisitions, and market expansion while monitoring regulatory changes is critical.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry research
Disclaimers:
This analysis is based on available information and is not financial advice. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mesa Laboratories Inc
Exchange NASDAQ | Headquaters Lakewood, CO, United States | ||
IPO Launch date 1995-01-25 | CEO, President & Director Mr. Gary M. Owens | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 730 | Website https://www.mesalabs.com |
Full time employees 730 | Website https://www.mesalabs.com | ||
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.